鲁抗医药及子公司多种药品拟中标全国药品集中采购

财中社12-19

财中社12月19日电鲁抗医药（600789）发布关于公司及控股子公司参与全国药品集中采购拟中标的公告。公司及其控股子公司赛特公司参加了第十批全国药品集中采购的投标，部分药品拟中选。拟中标的药品包括注射用青霉素钠、注射用哌拉西林钠、注射用氨苄西林钠和盐酸艾司洛尔注射液，拟中标数量和价格分别为：注射用青霉素钠1197.844元/支，注射用哌拉西林钠2123.989元/支，注射用氨苄西林钠384.206...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2492552146?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-19 16:20","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2492552146","market":"sh","top_or_hot":-1,"title":"鲁抗医药及子公司多种药品拟中标全国药品集中采购","media":"财中社","content":"<div>\n<p>财中社12月19日电鲁抗医药（600789）发布关于公司及控股子公司参与全国药品集中采购拟中标的公告。公司及其控股子公司赛特公司参加了第十批全国药品集中采购的投标，部分药品拟中选。拟中标的药品包括注射用青霉素钠、注射用哌拉西林钠、注射用氨苄西林钠和盐酸艾司洛尔注射液，拟中标数量和价格分别为：注射用青霉素钠1197.844元/支，注射用哌拉西林钠2123.989元/支，注射用氨苄西林钠384.206...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219165100ab8400cf&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>鲁抗医药及子公司多种药品拟中标全国药品集中采购</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n鲁抗医药及子公司多种药品拟中标全国药品集中采购\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-19 16:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219165100ab8400cf&s=b><strong>财中社</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财中社12月19日电鲁抗医药（600789）发布关于公司及控股子公司参与全国药品集中采购拟中标的公告。公司及其控股子公司赛特公司参加了第十批全国药品集中采购的投标，部分药品拟中选。拟中标的药品包括注射用青霉素钠、注射用哌拉西林钠、注射用氨苄西林钠和盐酸艾司洛尔注射液，拟中标数量和价格分别为：注射用青霉素钠1197.844元/支，注射用哌拉西林钠2123.989元/支，注射用氨苄西林钠384.206...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219165100ab8400cf&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0046","symbol_name":"生物疫苗","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219165100ab8400cf&s=b","article_id":"2492552146","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219165100ab8400cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2492552146","pubTimestamp":1734596441,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"公司及其控股子公司赛特公司参加了第十批全国药品集中采购的投标，部分药品拟中选。此次中标的产品均已通过仿制药质量和疗效一致性评价。2023年注射用青霉素钠、哌拉西林钠和氨苄西林钠的销售收入分别为1.61亿元、1.1亿元和6486万元，占公司2023年营业收入61.47亿元的2.62%、1.8%和1.06%。2024年前三季度，鲁抗医药实现收入46.67亿元，归母净利润3.47亿元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600789":"鲁抗医药","BK0046":"生物疫苗","BK0168":"禽流感","BK0239":"医药制造","BK0188":"融资融券"},"translate_title":"Lukang Pharmaceutical and its subsidiaries plan to win the bid for national centralized drug procurement","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600789":1},"content_text":"财中社12月19日电鲁抗医药（600789）发布关于公司及控股子公司参与全国药品集中采购拟中标的公告。公司及其控股子公司赛特公司参加了第十批全国药品集中采购的投标，部分药品拟中选。拟中标的药品包括注射用青霉素钠、注射用哌拉西林钠、注射用氨苄西林钠和盐酸艾司洛尔注射液，拟中标数量和价格分别为：注射用青霉素钠1197.844元/支，注射用哌拉西林钠2123.989元/支，注射用氨苄西林钠384.206元/支，盐酸艾司洛尔注射液184.8129元/支。此次中标的产品均已通过仿制药质量和疗效一致性评价。2023年注射用青霉素钠、哌拉西林钠和氨苄西林钠的销售收入分别为1.61亿元、1.1亿元和6486万元，占公司2023年营业收入61.47亿元的2.62%、1.8%和1.06%。2024年1-9月的销售收入分别为1.11亿元、7584万元和4293万元，占公司2024年1-9月营业收入46.67亿元的2.37%、1.63%和0.92%。如果最终中选并签订合同，将有助于公司扩大销售、增加生产负荷和提升品牌影响力。2024年前三季度，鲁抗医药实现收入46.67亿元，归母净利润3.47亿元。文章来源：财中社原标题：鲁抗医药及子公司多种药品拟中标全国药品集中采购","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2492552146"}